Technology area: Biotechnology & Pharmaceuticals
23 pending office actions • 19 art units • 22 examiners • 0 of 23 (0%) have an AI response strategy ready • 35 patents granted in the last 365 days
Universiteit Gent has 24 pending office actions in Biotechnology & Pharmaceuticals. The portfolio spans 23 distinct examiners and 20 distinct art units, demonstrating broad distribution across examination assignments. This structure supports a centralized docket framework with separate technical and procedural tracking for each matter.
LIU, TRACY is the busiest examiner, with 2 pending matters. That examiner has the largest stated concentration, but most prosecution activity remains distributed across the wider examiner and art-unit network.
Based on the USPTO statutory response window for each pending office action. 5 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 5 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (4%) |
| §103 only | 8 (35%) |
| §112 only | 3 (13%) |
| Double-patenting + other | 3 (13%) |
| Multi-statute (no §101) | 8 (35%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| LIU, TRACY | 2 | 54.5% | +26.9% |
| KU, SI MING | 1 | 72.8% | +32.8% |
| EPSTEIN, TODD MATTHEW | 1 | 60.8% | +43.6% |
| YU, HONG | 1 | 31.1% | +5.7% |
| ARIANI, KADE | 1 | 75.0% | +32.0% |
| HUSON, MONICA ANNE | 1 | 79.6% | +13.5% |
| WEISSBERGER, LUNA T | 1 | 75.2% | +24.1% |
| LANDSMAN, ROBERT S | 1 | 81.4% | +13.0% |
| COLLINS, CYNTHIA E | 1 | 82.2% | +9.0% |
| HUGHES, DEANDRA M | 1 | 78.2% | +18.8% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18691384 | AMINOPEPTIDASE N-SPECIFIC MONOCLONAL ANTIBODIES AND USES THEREOF | LANDSMAN, ROBERT S | — |
| 18600428 | Means and Methods for Improved Regeneration | COLLINS, CYNTHIA E | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17784859 | NON-VIRAL VECTORS COMPRISING POLYPROPYLENEIMINE | BOATENG, AFUA BAMFOAA | 67d overdue |
| 18857976 | MEDICAL IMPLANT FOR TREATMENT OF A SCAPULA FRACTURE | KU, SI MING | — |
| 18855098 | METHODS TO PRODUCE ACETYLATED AND NON-ACETYLATED GLYCOLIPID AMPHIPHILES | EPSTEIN, TODD MATTHEW | — |
| 18767360 | LIPID NANOPARTICLE-BASED ANTI-FENTANYL VACCINE | YU, HONG | — |
| 18723470 | Microbial communities | ARIANI, KADE | — |
| 18429576 | LASER APPARATUS AND METHOD FOR CONTROLLING THE LINEWIDTH OF THE EMITTED LASER BEAM | HUGHES, DEANDRA M | — |
| 18571533 | COMPOSITION AND PROCESS FOR AN INFILTRATION AND TRANSPORT MEDIUM FOR ADIPOSE TISSUE CELLS | NOBLE, MARCIA STEPHENS | — |
| 18549476 | TREATMENT OF EYE DISEASES WITH FRUCTOSYL-AMINO ACID OXIDASE | FAN, LYNN Y | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18029518 | Prebiotic Oral Care Compositions and Methods | LIU, TRACY | 15d |
| 18857976 | MEDICAL IMPLANT FOR TREATMENT OF A SCAPULA FRACTURE | KU, SI MING | — |
| 18855098 | METHODS TO PRODUCE ACETYLATED AND NON-ACETYLATED GLYCOLIPID AMPHIPHILES | EPSTEIN, TODD MATTHEW | — |
| 18723470 | Microbial communities | ARIANI, KADE | — |
| 18722254 | SOLUTION ELECTROSPUN FIBERS, COMPOSITIONS COMPRISING THE SAME AND A PROCESS OF MANUFACTURING THEREOF | HUSON, MONICA ANNE | — |
| 18698080 | DEVICE AND METHOD FOR CLOCK SYNCHRONISATION IN A WIRELESS NETWORK | WEISSBERGER, LUNA T | — |
| 18691384 | AMINOPEPTIDASE N-SPECIFIC MONOCLONAL ANTIBODIES AND USES THEREOF | LANDSMAN, ROBERT S | — |
| 18429576 | LASER APPARATUS AND METHOD FOR CONTROLLING THE LINEWIDTH OF THE EMITTED LASER BEAM | HUGHES, DEANDRA M | — |
| Art Unit | Apps |
|---|---|
| 1614 | 4 |
| 1691 | 2 |
| 3775 | 1 |
| 1652 | 1 |
| 1651 | 1 |
| 1742 | 1 |
| 2415 | 1 |
| 1647 | 1 |
| 1662 | 1 |
| 3992 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18857976 | MEDICAL IMPLANT FOR TREATMENT OF A SCAPULA FRACTURE | KU, SI MING | 3775 | §102§103 | Non-Final OA | — | Pending | Oct 18, 2024 |
| 18855098 | METHODS TO PRODUCE ACETYLATED AND NON-ACETYLATED GLYCOLIPID AMPHIPHILES | EPSTEIN, TODD MATTHEW | 1652 | §102§112Other | Non-Final OA | — | Pending | Oct 08, 2024 |
| 18767360 | LIPID NANOPARTICLE-BASED ANTI-FENTANYL VACCINE | YU, HONG | 1614 | §103§112 | Non-Final OA | — | Pending | Jul 09, 2024 |
| 18723470 | Microbial communities | ARIANI, KADE | 1651 | §103§112 | Non-Final OA | — | Pending | Jun 24, 2024 |
| 18722254 | SOLUTION ELECTROSPUN FIBERS, COMPOSITIONS COMPRISING THE SAME AND A PROCESS OF MANUFACTURING THEREOF | HUSON, MONICA ANNE | 1742 | §103 | Non-Final OA | — | Pending | Jun 20, 2024 |
| 18698080 | DEVICE AND METHOD FOR CLOCK SYNCHRONISATION IN A WIRELESS NETWORK | WEISSBERGER, LUNA T | 2415 | §103 | Final Rejection | — | Pending | Apr 03, 2024 |
| 18691384 | AMINOPEPTIDASE N-SPECIFIC MONOCLONAL ANTIBODIES AND USES THEREOF | LANDSMAN, ROBERT S | 1647 | §112 | Non-Final OA | — | Pending | Mar 12, 2024 |
| 18600428 | Means and Methods for Improved Regeneration | COLLINS, CYNTHIA E | 1662 | §102§103§112DP | Non-Final OA | — | Pending | Mar 08, 2024 |
| 18429576 | LASER APPARATUS AND METHOD FOR CONTROLLING THE LINEWIDTH OF THE EMITTED LASER BEAM | HUGHES, DEANDRA M | 3992 | §102§112 | Non-Final OA | — | Pending | Feb 01, 2024 |
| 18571533 | COMPOSITION AND PROCESS FOR AN INFILTRATION AND TRANSPORT MEDIUM FOR ADIPOSE TISSUE CELLS | NOBLE, MARCIA STEPHENS | 1632 | §102§103§112 | Non-Final OA | — | Pending | Dec 18, 2023 |
| 18570876 | Means and Methods to Regulate Gut Dysbiosis | LEWIS, PATRICK T | 1691 | §112 | Final Rejection | — | Pending | Dec 15, 2023 |
| 18552838 | MEANS AND METHOD FOR CYTOSOLIC DELIVERY | HAGHIGHATIAN, MINA | 1616 | §103 | Final Rejection | 12d | Pending | Sep 27, 2023 |
| 18549476 | TREATMENT OF EYE DISEASES WITH FRUCTOSYL-AMINO ACID OXIDASE | FAN, LYNN Y | 1759 | §101§102§103 | Non-Final OA | — | Pending | Sep 07, 2023 |
| 18547111 | Cation-Independent Mannose-6-Phosphate Receptor Binders | CHASE, CAROL ANN | 1646 | §102§103§112DP | Non-Final OA | — | Pending | Aug 18, 2023 |
| 18261292 | A METHOD TO PREPARE POCKETS OF ENCAPSULATED MATERIAL COMPRISING A CORE SURROUNDED BY AN ENCAPSULATION | ANGEBRANNDT, MARTIN J | 1737 | §103§112 | Non-Final OA | — | Pending | Jul 13, 2023 |
| 18260942 | SEALING STRIP FOR SEALING JOINTS BETWEEN THE SURFACES OF TWO ADJACENT COMPONENTS | KENNY, DANIEL J | 3633 | §103 | Final Rejection | — | Pending | Jul 11, 2023 |
| 18265366 | IONIZABLE LIPIDS | CARR, DEBORAH D | 1691 | §112 | Non-Final OA | — | Pending | Jun 05, 2023 |
| 18142147 | METHOD FOR DEPOSITING A RUTHENIUM-CONTAINING FILM ON A SUBSTRATE BY A CYCLICAL DEPOSITION PROCESS | CHEN, BRET P | 1718 | §102§112DP | Non-Final OA | 3d overdue | Pending | May 02, 2023 |
| 18029518 | Prebiotic Oral Care Compositions and Methods | LIU, TRACY | 1614 | §103 | Non-Final OA | 15d | Pending | Mar 30, 2023 |
| 17905482 | HYDROLYSIS-BASED PROBE AND METHOD FOR STR GENOTYPING | LU, FRANK WEI MIN | 1683 | §103 | Non-Final OA | — | Pending | Sep 01, 2022 |
| 17784859 | NON-VIRAL VECTORS COMPRISING POLYPROPYLENEIMINE | BOATENG, AFUA BAMFOAA | 1614 | §103§112 | Non-Final OA | 67d overdue | Pending | Jun 13, 2022 |
| 17248815 | Prebiotic Oral Care Compositions Containing Carboxylic Acids | LIU, TRACY | 1614 | §103 | Non-Final OA | — | Pending | Feb 09, 2021 |
| 17128599 | BISPECIFIC SIGNALING AGENTS AND USES THEREOF | GAO, ASHLEY HARTMAN | 1678 | §103Other | Non-Final OA | 33d | Pending | Dec 21, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialUniversiteit Gent has 23 pending office actions as of October 2026, spread across 19 art units and 22 examiners.
Tracy Liu has the most, with 2 of Universiteit Gent's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
